Institutional investors hold a majority ownership of MRK through the 75.93% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended June 2015, these large investors purchased a net $3.1 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SANDERS CAPITAL LLC Bought 9.0 Million shares of Merck
INDEPENDENT FRANCHISE PARTNERS L... Bought 7.9 Million shares of Merck
MANNING & NAPIER ADVISORS LLC Bought 5.9 Million shares of Merck